Published in J Biomol NMR on March 12, 2009
Cell signaling, post-translational protein modifications and NMR spectroscopy. J Biomol NMR (2012) 1.06
Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. Proc Natl Acad Sci U S A (2015) 0.94
Lysine methylation strategies for characterizing protein conformations by NMR. J Biomol NMR (2012) 0.83
Utilization of lysine ¹³C-methylation NMR for protein-protein interaction studies. J Biomol NMR (2012) 0.82
Structural study of a small molecule receptor bound to dimethyllysine in lysozyme. Chem Sci (2015) 0.79
Reductive methylation and mutation of an anthrax toxin fusion protein modulates its stability and cytotoxicity. Sci Rep (2014) 0.79
Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists. Mol Cell Biochem (2017) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Ca2+-induced hydrophobic site on calmodulin: application for purification of calmodulin by phenyl-Sepharose affinity chromatography. Biochem Biophys Res Commun (1982) 3.87
Reductive alkylation of amino groups in proteins. Biochemistry (1968) 3.47
Lysine methylation as a routine rescue strategy for protein crystallization. Structure (2006) 3.14
The channel architecture of aquaporin 0 at a 2.2-A resolution. Proc Natl Acad Sci U S A (2004) 2.69
Reductive alkylation of lysine residues to alter crystallization properties of proteins. Methods Enzymol (1997) 1.92
Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem (2006) 1.89
Structural consequences of reductive methylation of lysine residues in hen egg white lysozyme: an X-ray analysis at 1.8-A resolution. Biochemistry (1993) 1.65
Determination of the side chain pKa values of the lysine residues in calmodulin. J Biol Chem (1993) 1.28
Heteronuclear NMR spectroscopy for lysine NH(3) groups in proteins: unique effect of water exchange on (15)N transverse relaxation. J Am Chem Soc (2007) 1.26
Residue-specific pKa determination of lysine and arginine side chains by indirect 15N and 13C NMR spectroscopy: application to apo calmodulin. J Am Chem Soc (2007) 1.25
Measurement and modelling of sequence-specific pKa values of lysine residues in calbindin D9k. J Mol Biol (1996) 1.13
Intramolecular interactions of amino groups in 13C reductively methylated hen egg-white lysozyme. J Biol Chem (1982) 1.09
The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase. Biochemistry (1996) 1.04
Direct evidence for deprotonation of a lysine side chain buried in the hydrophobic core of a protein. J Am Chem Soc (2008) 1.00
Structure of gamma-chymotrypsin in the range pH 2.0 to pH 10.5 suggests that gamma-chymotrypsin is a covalent acyl-enzyme adduct at low pH. Int J Biol Macromol (1991) 0.96
X-ray crystallographic analysis of pokeweed antiviral protein-II after reductive methylation of lysine residues. Biochem Biophys Res Commun (2000) 0.91
Detection of protein-ligand interactions by NMR using reductive methylation of lysine residues. J Biomol NMR (2008) 0.90
Mass spectrometry assisted assignment of NMR resonances in reductively 13C-methylated proteins. J Am Chem Soc (2005) 0.90
A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies. J Mol Biol (2000) 0.84
Effects of pH on conformational properties related to the toxicity of Bacillus thuringiensis delta-endotoxin. Biochim Biophys Acta (1992) 0.80
Biophysical properties of human erythrocyte spectrin at alkaline pH: implications for spectrin structure, function, and association. Biochemistry (1998) 0.79
Determination of lysine pK values using [5-13C]lysine: application to the lyase domain of DNA Pol beta. J Am Chem Soc (2006) 0.78
Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol (2005) 3.44
Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc Res (2005) 2.79
Diluting abundant spins by isotope edited radio frequency field assisted diffusion. J Am Chem Soc (2004) 2.50
At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ Res (2004) 2.06
Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCepsilon phosphorylation. J Mol Cell Cardiol (2006) 2.06
Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res (2007) 2.05
Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest (2008) 2.02
Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem (2003) 1.99
Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A (2002) 1.98
Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem (2006) 1.89
Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem (2003) 1.87
Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing. J Physiol (2003) 1.85
Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. Am J Physiol Heart Circ Physiol (2007) 1.84
Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis (2005) 1.83
Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res (2003) 1.82
The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun (2007) 1.77
Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation. J Biol Chem (2008) 1.75
The troponin C G159D mutation blunts myofilament desensitization induced by troponin I Ser23/24 phosphorylation. Circ Res (2007) 1.74
Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. Biophys J (2007) 1.61
Phosphorylation-dependent conformational transition of the cardiac specific N-extension of troponin I in cardiac troponin. J Mol Biol (2007) 1.60
Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation (2006) 1.53
p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity. Circ Res (2007) 1.48
A dominant role of cardiac molecular motors in the intrinsic regulation of ventricular ejection and relaxation. Physiology (Bethesda) (2007) 1.48
A non-equilibrium isoelectric focusing method to determine states of phosphorylation of cardiac troponin I: identification of Ser-23 and Ser-24 as significant sites of phosphorylation by protein kinase C. J Mol Cell Cardiol (2004) 1.48
Sensitive high resolution inverse detection NMR spectroscopy of proteins in the solid state. J Am Chem Soc (2003) 1.47
Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I. J Biol Chem (2008) 1.46
Differential effects of phosphorylation of regions of troponin I in modifying cooperative activation of cardiac thin filaments. J Mol Cell Cardiol (2009) 1.46
Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity. Circ Res (2012) 1.39
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J (2005) 1.38
Integration of troponin I phosphorylation with cardiac regulatory networks. Circ Res (2013) 1.38
Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. Circ Res (2009) 1.33
Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res (2004) 1.32
Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res (2007) 1.29
FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling. J Mol Cell Cardiol (2009) 1.29
Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform. Circulation (2010) 1.29
The significance of regulatory light chain phosphorylation in cardiac physiology. Arch Biochem Biophys (2011) 1.27
AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. J Biol Chem (2012) 1.27
Cardiac troponin T isoforms affect the Ca(2+) sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart. J Biol Chem (2004) 1.27
Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells. Circ Res (2007) 1.26
Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol (2006) 1.25
Protein phosphorylation and signal transduction in cardiac thin filaments. J Biol Chem (2011) 1.23
Molecular and integrated biology of thin filament protein phosphorylation in heart muscle. Ann N Y Acad Sci (2004) 1.22
PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation. Basic Res Cardiol (2010) 1.21
Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts. Am J Physiol Heart Circ Physiol (2008) 1.20
Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation (2011) 1.18
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation (2010) 1.18
Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary. Circulation (2008) 1.17
Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes. Am J Physiol Cell Physiol (2008) 1.16
Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. J Biol Chem (2008) 1.15
Protein kinase C zeta. A novel regulator of both phosphorylation and de-phosphorylation of cardiac sarcomeric proteins. J Biol Chem (2007) 1.14
Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties. J Mol Cell Cardiol (2012) 1.14
Functional effects of rho-kinase-dependent phosphorylation of specific sites on cardiac troponin. Circ Res (2005) 1.14
Review focus series: sarcomeric proteins as key elements in integrated control of cardiac function. Cardiovasc Res (2008) 1.12
A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival. J Biol Chem (2012) 1.12
Troponin I serines 43/45 and regulation of cardiac myofilament function. Am J Physiol Heart Circ Physiol (2002) 1.11
p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility. Am J Physiol Regul Integr Comp Physiol (2007) 1.11
Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury. Am J Physiol Heart Circ Physiol (2011) 1.10
Negative charges at protein kinase C sites of troponin I stabilize the inactive state of actin. Biophys J (2007) 1.09
Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. J Mol Cell Cardiol (2011) 1.09
Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. J Physiol (2004) 1.09
The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. Mol Cell Biochem (2004) 1.08
Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction. Am J Physiol Heart Circ Physiol (2005) 1.08
Phosphorylation of cardiac troponin I at protein kinase C site threonine 144 depresses cooperative activation of thin filaments. J Biol Chem (2010) 1.08
Removal of the cardiac troponin I N-terminal extension improves cardiac function in aged mice. J Biol Chem (2010) 1.07
A novel, in-solution separation of endogenous cardiac sarcomeric proteins and identification of distinct charged variants of regulatory light chain. Mol Cell Proteomics (2010) 1.05
Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo. Am J Physiol Heart Circ Physiol (2004) 1.04
Identification of a region of troponin I important in signaling cross-bridge-dependent activation of cardiac myofilaments. J Biol Chem (2006) 1.04
PKCepsilon increases phosphorylation of the cardiac myosin binding protein C at serine 302 both in vitro and in vivo. Biochemistry (2007) 1.04
Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy. Proteomics (2008) 1.04
Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca(2+) activation. Am J Physiol Heart Circ Physiol (2002) 1.03
Expression of slow skeletal troponin I in adult mouse heart helps to maintain the left ventricular systolic function during respiratory hypercapnia. Circ Res (2005) 1.03
High-sensitivity observation of dipolar exchange and NOEs between exchangeable protons in proteins by 3D solid-state NMR spectroscopy. J Am Chem Soc (2003) 1.03
Derivation of structural restraints using a thiol-reactive chelator. FEBS Lett (2002) 1.03
Actin capping protein: an essential element in protein kinase signaling to the myofilaments. Circ Res (2002) 1.02
Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target. ACS Chem Biol (2007) 1.02
alpha-Adrenergic response and myofilament activity in mouse hearts lacking PKC phosphorylation sites on cardiac TnI. Am J Physiol Heart Circ Physiol (2002) 1.01
13C CPMAS spectroscopy of deuterated proteins: CP dynamics, line shapes, and T1 relaxation. J Am Chem Soc (2005) 1.00
Some cardiomyopathy-causing troponin I mutations stabilize a functional intermediate actin state. Biophys J (2009) 1.00
Retracted A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J Biol Chem (2013) 1.00
ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. Biochem J (2013) 0.99
Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation. Circ Res (2002) 0.99
Regulation of cardiac excitation and contraction by p21 activated kinase-1. Prog Biophys Mol Biol (2009) 0.99
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium. Am J Physiol Heart Circ Physiol (2013) 0.97
Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2010) 0.97
Functional importance of the carboxyl-terminal region of striated muscle tropomyosin. J Biol Chem (2003) 0.96
Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C. Front Physiol (2013) 0.95
Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43. Cardiovasc Res (2011) 0.94
Sites of intra- and intermolecular cross-linking of the N-terminal extension of troponin I in human cardiac whole troponin complex. J Biol Chem (2009) 0.94